A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -17.65% this year. Over the last six months, there has been a stronger performance of -28.91%. The price of LAB fallen by 4.00% during the last 30 days period. For the last 5-days stocks have improved 13.04%.
Standard BioTools Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $3.04 on 04/09/24, while the lowest value for the same period was recorded at $1.21 on 08/01/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of LAB Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Standard BioTools Inc’s current trading price is -40.13% away from its 52-week high, while its distance from the 52-week low is 50.41%. The stock’s price range during this period has varied between$1.21 and $3.04. The Standard BioTools Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.72 million for the day, a figure considerably lower than their average daily volume of 1.86 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Standard BioTools Inc (LAB) has experienced a quarterly decline of -12.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 677.51M and boasts a workforce of 539 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9162, with a change in price of -0.0200. Similarly, Standard BioTools Inc recorded 2,237,614 in trading volume during the last 100 days, posting a change of -1.09%.
LAB’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.06.
LAB Stock Stochastic Average
As of today, Standard BioTools Inc’s raw stochastic average for the last 50 days stands at 41.86%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 41.86%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 29.84% and 23.00%, respectively.
